3299.0
HIV and substance use
Monday, November 4, 2013: 2:30 p.m. - 3:30 p.m.
Poster
Board 1
Multilevel pharmacy-randomized intervention targeting IDUs and pharmacy practice: Impact of providing HIV risk reduction materials during the syringe sale on idu risk behavior
Alexis Rivera, MPH, Natalie Crawford, PhD, Silvia Amesty, MD, MPH, MSEd, Alezandria Turner, PhD, Katherine Harripersaud, MPH and Crystal Fuller, PhD, MPH
Board 2
Community affiliation, participation, gay identification and unprotected anal sex among young substance-using MSM in four u.s. cities
Pilgrim Spikes, PhD, MPH, MSW, Gordon Mansergh, PhD, Stephen Flores, PhD, Grant Colfax, MD and Beryl Koblin, PhD
Board 3
Gender difference in HIV sexual risk behavior among substance use program patients in US
Yue Pan, MS, Daniel Feaster, PhD, Weize Wang, MA, Rui Duan, MPH, Zoilyn L Gomez, MPH, Ke-Sheng Wang, PhD, Tiffany L Kyle, PhD, Susan Tross, PHD and Lisa R. Metsch, PhD
Board 7
Patterns of substance use and engagement in sexual risk behavior among HIV positive adults over 50
Tyrel Starks, PhD, Brett Millar, BA, David Marcotte, PhD, Kailip Boonrai, BS, Zak Hill-Whilton, BA and Jeffrey T. Parsons, PhD
Board 8
High rates of co-occurring mental health and other substance abuse problems in men who have sex with men (MSM) screening for a behavioral intervention to reduce crystal methamphetamine use and HIV risk behaviors
Amaya Perez-Brumer, BA, Jaclyn White, MPH, David Pantalone, PhD, Michael Garber, MSW, Steven A. Safren, PhD, ABPP and Matthew J. Mimiaga, ScD, MPH
See individual abstracts for presenting author's disclosure statement and author's information.
Organized by: HIV/AIDS
Endorsed by: Epidemiology, Alcohol, Tobacco, and Other Drugs
